Abstract:Approximately 15%-27% of patients with locally advanced rectal cancer (LARC) treated with the neoadjuvant concurrent chemoradiotherapy (nCCRT) could achieve pathological complete remission (pCR). The intestinal microbes participate in the regulation of the oncogenesis, progression and therapeutic effect of gastrointestinal tumors by producing metabolites and toxins, affecting cell proliferation, modulating inflammation and immunity, and inducing DNA damage. Whether the intestinal microbial alterations determine radiosensitivity for patients delivered nCCRT is not clear. We performed a longitudinal study to examine the alterations of rectal and fecal microbiome for patients with LARC patients throughout nCCRT. Serial fecal samples of 39 patients with newly diagnosed LARC were collected at before, 3 weeks during, and after nCCRT. Microbiome characteristics were identified via 16S rDNA sequencing. Responses of the nCCRT were distinguished as "Good" and "Poor" in accordance with "TRG0-1" (tumor regression grade, the AJCC 8th edition) and "TRG2-3" by two independent pathologists. Shannon diversity index (SDI) and Chao1 diversity index (CDI) were used to depict the microbiome diversity and richness. Microbiome's alterations of paired samples at three timepoints throughout nCCRT was analyzed by Wilcoxon signed-rank test. Heatmap shows top two families of each patient's gut microbiome throughout nCCRT. Fecal SDI was significantly decreased at 3 weeks during and after nCCRT (P = 0.01; P = 0.022) while 12 pairs of matched tumoral and peritumoral microbiome before nCCRT treatment showed no difference (P = 0.898). CDI of "Good response" group was obviously higher than "Poor response" in integrated three timepoints (P = 0.0347). 6 of 39 patients had relatively stable dominant bacteria at family level, while the remained 36 demonstrated a sharp variation of dominant bacteria via longitudinal analysis. The abundance of 6 genera Porphyromonas (P = 0.0038), Parvimonas (P<0.001), Peptostreptococcus (P<0.001), Fusobacterium (P<0.001), Ezakiella (P = 0.0017), unidentified_Clostridiales (P = 0.0038) predominantly decreased throughout the whole nCCRT treatment. Fecal microbiome diversity decreased throughout nCCRT and patients of "Good response" had higher richness at integral level. Majority of patients had altered dominant bacteria during the whole nCCRT, while minority remained relatively stable. nCCRT may affect the fecal microbiome and then result in response heterogeneity of LARC patients. The abundance of 6 genera Porphyromonas, Parvimonas, Peptostreptococcus, Fusobacterium, Ezakiella, unidentified_Clostridiales decreased most prominently throughout nCCRT.

Preliminary study on gut microbiota prediction of radiation enteritis in patients with cervical and endometrial cancers

The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma

[Relationship Between Chronic Radiation Enteritis of Cervical Cancer and Gut Microbiota].

Correlation of immune function:gut microbiota and radiation enteritis in patients with cervical cancer

Investigating the relationship between postoperative radiotherapy and intestinal flora in rectal cancer patients: a study on efficacy and radiation enteritis

Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy

Gut microbiota shifts in patients with gastric cancer in perioperative period.

Gut Microbiota Characteristics Are Associated With Severity of Acute Radiation-Induced Esophagitis

Altered Diversity and Composition of the Gut Microbiome in Patients with Cervical Cancer

Research progress and treatment of radiation enteritis and gut microbiota

The intra-tumoral microbiome as a potential biomarker of response to external beam radiation therapy in cervical cancer

Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report

The Impact of Gut Microbiota on Radiation-Induced Enteritis

Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation

The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review

The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study

Longitudinal Analysis of Fecal Microbiome Diversity During the Neoadjuvant Concurrent Chemoradiotherapy of Patients with Locally Advanced Rectal Cancer

Changes of intestinal microbiota in colorectal cancer and its potential ability to predict disease

Relationship between Gut Commensal Bacteria and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Microbial Characteristics of Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiation Therapy According to Pathologic Response

Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis